Mikhail Chumakov Mikhail Chumakov Mikhail Petrovich Chumakov () (November 14, 1909 – June 11, 1993) was a Soviet microbiologist and virologist most famous for conducting pivotal large-scale clinical trials that led to licensing of the Oral Polio Vaccine (OPV) developed by Albert B. Sabin. Chumakov graduated in 1931 from Moscow State University Medical School that was later transformed into I.M. Sechenov Moscow Medical Academy. In 1937 Chumakov participated in a scientific expedition to Khabarovsk region of Soviet Far East that was led by Professor . Together with his colleagues he discovered the etiology of a new transmissible neurological disease called tick-borne encephalitis
HPV vaccine at the University of Queensland have been accorded priority under U.S. patent law for the invention of the HPV vaccine's basis, the VLPs. In 2006, the FDA approved the first preventive HPV vaccine, marketed by Merck & Co. under the trade name Gardasil. According to a Merck press release, in the second quarter of 2007, it had been approved in 80 countries, many under fast-track or expedited review. Early in 2007, GlaxoSmithKline filed for approval in the United States for a similar preventive HPV vaccine, known as Cervarix. In June 2007 this vaccine was licensed in Australia, and it was